Pharma-Bio Serv (PBSV) Payables (2010 - 2026)

Pharma-Bio Serv (PBSV) has reported Payables for 16 consecutive years, with $978541.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Payables rose 4.33% year-over-year to $978541.0; the trailing twelve-month figure through Apr 2026 stood at $978541.0 (up 4.33% YoY), and the FY2025 full-year result was $991169.0, down 12.1% from the prior year.
• Payables eased to $978541.0 in Q2 2026 per PBSV's latest filing, from $2.6 million in the prior quarter.
• Across five years, Payables topped out at $2.8 million in Q1 2024 and bottomed at $874379.0 in Q3 2025.
• Historically, Payables has averaged $1.4 million across 5 years, with a median of $1.4 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Payables plunged 65.83% in 2025, then soared 171.94% in 2026.
• Over 5 years, Payables stood at $1.6 million in 2022, then declined by 9.95% to $1.5 million in 2023, then retreated by 23.15% to $1.1 million in 2024, then decreased by 12.1% to $991169.0 in 2025, then slipped by 1.27% to $978541.0 in 2026.
• According to Business Quant data, Payables over the past three periods registered $978541.0, $2.6 million, and $991169.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.